Page 62 - Read Online

Page 24 of 24 Saier et al. J Cancer Metastasis Treat 2021;7:43 https://dx.doi.org/10.20517/2394-4722.2021.87

dual COX-2/sEH inhibitor. Proc Natl Acad Sci U S A 2019;116:1698-703. DOI PubMed PMC
193. Karagiannis GS, Pastoriza JM, Wang Y, et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-
mediated mechanism. Sci Transl Med 2017;9:eaan0026. DOI PubMed PMC
194. Shaked Y. The pro-tumorigenic host response to cancer therapies. Nat Rev Cancer 2019;19:667-85. DOI PubMed
195. Volk-Draper L, Hall K, Griggs C, et al. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer
Res 2014;74:5421-34. DOI PubMed PMC
196. Sulciner ML, Serhan CN, Gilligan MM, et al. Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med
2018;215:115-40. DOI PubMed PMC
197. Gilligan MM, Gartung A, Sulciner ML, et al. Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proc Natl Acad
Sci U S A 2019;116:6292-7. DOI PubMed PMC
198. Liu H, Zeng J, Huang W, et al. Colorectal cancer is associated with a deficiency of Lipoxin A(4), an endogenous anti-inflammatory
mediator. J Cancer 2019;10:4719-30. DOI PubMed PMC
199. Panigrahy D, Edin ML, Lee CR, et al. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin
Invest 2012;122:178-91. DOI PubMed PMC
200. Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest
2018;128:2657-69. DOI PubMed PMC
201. Sulciner ML, Gartung A, Gilligan MM, Serhan CN, Panigrahy D. Targeting lipid mediators in cancer biology. Cancer Metastasis Rev
2018;37:557-72. DOI PubMed
202. Ye Y, Scheff NN, Bernabé D, et al. Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.
Neuropharmacology 2018;139:182-93. DOI PubMed
203. Serhan CN. The resolution of inflammation: the devil in the flask and in the details. FASEB J 2011;25:1441-8. DOI PubMed PMC
204. Sharma P, Allison JP. The future of immune checkpoint therapy. Science 2015;348:56-61. DOI PubMed
205. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92-101. DOI PubMed PMC
206. Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther
2021;218:107670. DOI PubMed PMC
207. Chiang N, Serhan CN, Dahlén SE, et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Pharmacol Rev 2006;58:463-87. DOI PubMed
208. Liu C, Guan H, Cai C, Li F, Xiao J. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced
bone loss. Exp Cell Res 2017;352:293-303. DOI PubMed